Brought to you by 
GE Med Systems, Amersham enter PET agreement
13 Oct 2021
Executive Summary
GE Medical Systems and Amersham Health (formerly Nycomed Amersham Imaging; diagnostic imaging and therapeutics) have agreed to jointly develop positron emission tomography (PET)-based molecular diagnostic imaging technologies and systems to detect early symptoms for a range of diseases including cancer and Parkinson's disease.
Deal Industry
- Medical Devices
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
-
Diagnostic Imaging Equipment & Supplies
Deal Status
- Final
Deal Type
-
Alliance
- R&D (No Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
GE Med Systems, Amersham enter PET agreement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice